JP2004018440A5 - - Google Patents

Download PDF

Info

Publication number
JP2004018440A5
JP2004018440A5 JP2002174402A JP2002174402A JP2004018440A5 JP 2004018440 A5 JP2004018440 A5 JP 2004018440A5 JP 2002174402 A JP2002174402 A JP 2002174402A JP 2002174402 A JP2002174402 A JP 2002174402A JP 2004018440 A5 JP2004018440 A5 JP 2004018440A5
Authority
JP
Japan
Prior art keywords
group
powdered
composition according
hydrogen atom
inhalant composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002174402A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004018440A (ja
JP3691459B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from JP2002174402A external-priority patent/JP3691459B2/ja
Priority to JP2002174402A priority Critical patent/JP3691459B2/ja
Priority to TW092115547A priority patent/TW200402313A/zh
Priority to AU2003242369A priority patent/AU2003242369A1/en
Priority to PCT/JP2003/007527 priority patent/WO2003105859A1/ja
Priority to EP03733409A priority patent/EP1514549A4/en
Priority to US10/514,563 priority patent/US20050163724A1/en
Priority to CA002488026A priority patent/CA2488026A1/en
Priority to CNB03813845XA priority patent/CN1272010C/zh
Priority to KR10-2004-7019153A priority patent/KR20050008739A/ko
Publication of JP2004018440A publication Critical patent/JP2004018440A/ja
Publication of JP2004018440A5 publication Critical patent/JP2004018440A5/ja
Publication of JP3691459B2 publication Critical patent/JP3691459B2/ja
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2002174402A 2002-06-14 2002-06-14 粉末状吸入剤組成物 Expired - Lifetime JP3691459B2 (ja)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP2002174402A JP3691459B2 (ja) 2002-06-14 2002-06-14 粉末状吸入剤組成物
TW092115547A TW200402313A (en) 2002-06-14 2003-06-09 Powdery respiratory tonic composition
CA002488026A CA2488026A1 (en) 2002-06-14 2003-06-13 Powdery respiratory tonic composition
PCT/JP2003/007527 WO2003105859A1 (ja) 2002-06-14 2003-06-13 粉末状吸入剤組成物
EP03733409A EP1514549A4 (en) 2002-06-14 2003-06-13 RESPIRATORY TONIC COMPOSITION IN POWDER
US10/514,563 US20050163724A1 (en) 2002-06-14 2003-06-13 Powdery respiratory tonic composition
AU2003242369A AU2003242369A1 (en) 2002-06-14 2003-06-13 Powdery respiratory tonic composition
CNB03813845XA CN1272010C (zh) 2002-06-14 2003-06-13 粉末状吸入剂组合物
KR10-2004-7019153A KR20050008739A (ko) 2002-06-14 2003-06-13 분말상 흡입제 조성물

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002174402A JP3691459B2 (ja) 2002-06-14 2002-06-14 粉末状吸入剤組成物

Publications (3)

Publication Number Publication Date
JP2004018440A JP2004018440A (ja) 2004-01-22
JP2004018440A5 true JP2004018440A5 (enExample) 2004-12-09
JP3691459B2 JP3691459B2 (ja) 2005-09-07

Family

ID=29727967

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002174402A Expired - Lifetime JP3691459B2 (ja) 2002-06-14 2002-06-14 粉末状吸入剤組成物

Country Status (9)

Country Link
US (1) US20050163724A1 (enExample)
EP (1) EP1514549A4 (enExample)
JP (1) JP3691459B2 (enExample)
KR (1) KR20050008739A (enExample)
CN (1) CN1272010C (enExample)
AU (1) AU2003242369A1 (enExample)
CA (1) CA2488026A1 (enExample)
TW (1) TW200402313A (enExample)
WO (1) WO2003105859A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
CO5310534A1 (es) * 2000-08-05 2003-08-29 Glaxo Group Ltd Nuevos derivados de androstano anti-inflamatorios
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
ES2314052T3 (es) 2001-04-30 2009-03-16 Glaxo Group Limited Derivados de ester de 17beta-carbotioato de androstano con un grupo ester ciclico en la posicion 17alfa.
US20040248867A1 (en) * 2001-06-12 2004-12-09 Keith Biggadike Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
PE20090907A1 (es) * 2007-07-21 2009-08-05 Boehringer Ingelheim Int Nuevos medicamentos pulverulentos que contienen tiotropio y salmeterol, asi como lactosa como excipiente
UA118861C2 (uk) * 2013-12-06 2019-03-25 Оріон Корпорейшн Спосіб отримання сухих порошкових композицій для інгаляцій

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
JPH07116215B2 (ja) * 1989-04-19 1995-12-13 エスエス製薬株式会社 新規なステロイド化合物
US5376386A (en) * 1990-01-24 1994-12-27 British Technology Group Limited Aerosol carriers
US5767152A (en) * 1995-05-04 1998-06-16 Nielsen; Thor Bagger Composition and methods for stimulating hair growth
US6315985B1 (en) * 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
GB9925934D0 (en) * 1999-11-03 1999-12-29 Glaxo Group Ltd Novel apparatus and process
SE0002822L (sv) * 2000-08-04 2002-01-29 Microdrug Ag Elektropulver
AU2001283438A1 (en) * 2000-08-21 2002-03-04 Aeropharm Technology Incorporated A method of stabilizing a dry powder pharmaceutical formulation
CA2416563A1 (en) * 2000-09-12 2002-03-21 Pharmacia & Upjohn Company Pharmaceutical composition having specific water activity
JP3691487B2 (ja) * 2000-12-22 2005-09-07 久光メディカル株式会社 炎症性気道疾患の予防・治療剤

Similar Documents

Publication Publication Date Title
JP2004018440A5 (enExample)
JP2013507423A5 (enExample)
JP2005298818A5 (enExample)
JP2005522421A5 (enExample)
JP2003521556A5 (enExample)
JP2005504811A5 (ja) 置換ペンタセン化合物、半導体デバイス及び物品
JP2010514786A5 (enExample)
JP2005520923A5 (enExample)
JP2010534247A5 (enExample)
JPH10265454A5 (enExample)
RU2013113965A (ru) Применение стеарата магния в составах сухого порошка для ингаляции
JPH10330688A5 (enExample)
JP2002519425A5 (enExample)
JP2005170966A5 (enExample)
JP2005511545A5 (enExample)
JP2005514478A5 (enExample)
JP2004530737A5 (enExample)
JP2005526773A5 (enExample)
JP2002506864A5 (enExample)
JP2005529175A5 (enExample)
JP2011508779A5 (enExample)
WO2017142990A1 (en) Halogen-based electrolyte containing carbon
JP2004233661A5 (enExample)
JP2005504738A5 (enExample)
JP2005526149A5 (enExample)